Toshida K, Itoh S, Yoshiya S, Nagao Y, et al. Pretreatment eosinophil count predicts response to atezolizumab plus bevacizumab therapy in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2023 Dec 12. doi: 10.1111/jgh.16441.
PMID: 38084637